Home
Sun Pharma Advanced Research Company Ltd EPS
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fsun-pharma-advanced-research-company-ltd.png&w=128&q=75)
Sun Pharma Advanced Research Company Ltd
NSE: SPARC
EPS
Key Highlights
- The Earning per Share of Sun Pharma Advanced Research Company Ltd is ₹ -11.97 as of 12 Feb 25 .
- The earning per share of Sun Pharma Advanced Research Company Ltd changed from ₹ -2.94 to ₹ -2.45 over 7 quarters. This represents a CAGR of -9.89% .
Historical Earning per Share of Sun Pharma Advanced Research Company Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Sun Pharma Advanced Research Company Ltd
Company Fundamentals for Sun Pharma Advanced Research Company Ltd
Market Cap
4,742 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
37.7
Day’s High
150.75
Day’s Low
142.0
DTE
0.5
ROE
-307.9
52 Week High
474.0
52 Week Low
142.0
ROCE
-130.8
Market Price of Sun Pharma Advanced Research Company Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 146.15 |
11 Feb 2025 | 150.05 |
10 Feb 2025 | 156.55 |
07 Feb 2025 | 158.85 |
06 Feb 2025 | 159.55 |
05 Feb 2025 | 160 |
04 Feb 2025 | 159 |
03 Feb 2025 | 155.5 |
01 Feb 2025 | 158.9 |
31 Jan 2025 | 160.05 |
SWOT Analysis Of Sun Pharma Advanced Research Company Ltd
BlinkX Score for Sun Pharma Advanced Research Company Ltd
Asset Value vs Market Value of Sun Pharma Advanced Research Company Ltd
Market Value
₹ 4,743
Asset Value
Value addition
15.0 X
₹ 297
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Sun Pharma Advanced Research Company Ltd | 4742 | - |
Sun Pharmaceuticals Industries Ltd | 406363 | 49.16 |
Divis Laboratories Ltd | 158396 | 77.86 |
Cipla Ltd | 117088 | 61.78 |
Torrent Pharmaceuticals Ltd | 103663 | 55.02 |
Dr Reddys Laboratories Ltd | 101458 | 64.37 |
Company | |
---|---|
Sun Pharma Advanced Research Company Ltd | 4742 |
Sun Pharmaceuticals Industries Ltd | 406363 |
Divis Laboratories Ltd | 158396 |
Cipla Ltd | 117088 |
Torrent Pharmaceuticals Ltd | 103663 |
Dr Reddys Laboratories Ltd | 101458 |
Historical Market Cap of Sun Pharma Advanced Research Company Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Sun Pharma Advanced Research Company Ltd
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Sun Pharma Advanced Research Company Ltd
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sun Pharma Advanced Research Company Ltd
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sun Pharma Advanced Research Company Ltd
Dividend Payout Over Time
Sun Pharma Advanced Research Company Ltd News Hub
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun
Read more
05 Aug 24
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se
Read more
04 Nov 24
Sun Pharma Advanced Research Company to convene board meeting
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on
Read more
25 Oct 24
SPARC drops as Q2 net loss widens to Rs 107 crore
Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.
Read more
04 Nov 24